Cargando…
Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice
Obesity is caused by an excess storage of body fat, resulting from a chronic imbalance between energy intake and expenditure. Gentiana lutea L. (GL) root has been reported to reduce lipid accumulation in the aortic wall of diabetic rats. Here, we performed fractionation and isolation of the bioactiv...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100558/ https://www.ncbi.nlm.nih.gov/pubmed/29987205 http://dx.doi.org/10.3390/molecules23071663 |
_version_ | 1783348902465896448 |
---|---|
author | Park, Eunkuk Kim, Jeonghyun Yeo, Subin Kim, Gijeong Ko, Eun-Hee Lee, Sang Woo Li, Wan Yi Choi, Chun Whan Jeong, Seon-Yong |
author_facet | Park, Eunkuk Kim, Jeonghyun Yeo, Subin Kim, Gijeong Ko, Eun-Hee Lee, Sang Woo Li, Wan Yi Choi, Chun Whan Jeong, Seon-Yong |
author_sort | Park, Eunkuk |
collection | PubMed |
description | Obesity is caused by an excess storage of body fat, resulting from a chronic imbalance between energy intake and expenditure. Gentiana lutea L. (GL) root has been reported to reduce lipid accumulation in the aortic wall of diabetic rats. Here, we performed fractionation and isolation of the bioactive constituent(s) that may be responsible for the antiadipogenic effects of the GL root extract. A single compound, loganic acid, was identified as a candidate component in the 30% ethanol extract of GL. Loganic acid treatment significantly decreased the adipocyte differentiation of 3T3-L1 preadipocytes in a dose-dependent manner. The expression of key adipogenesis-related genes such as adiponectin (Adipoq), peroxisome proliferator-activated receptor gamma (Pparg), lipoprotein lipase (Lpl), perilipin1 (Plin1), fatty acid binding protein 4 (Fabp4), glucose transporter type 4 (Slc2a4), CCAAT/enhancer-binding protein alpha (Cebpa), and tumor necrosis factor-alpha (Tnf) were significantly reduced following treatment with loganic acid. In vivo experiments in an ovariectomy-induced obesity mouse model showed that loganic acid (oral administration with 10 and 50 mg/kg/day) significantly inhibited body weight gain, total fat increase, fatty hepatocyte deposition in the liver, and adipocyte enlargement in the abdominal visceral fat tissues. These results suggest that loganic acid in the GL root extract has antiadipogenic effects in vitro and in vivo. Loganic acid may be beneficial for the prevention and treatment of obesity, particularly in menopausal obese women. |
format | Online Article Text |
id | pubmed-6100558 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61005582018-11-13 Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice Park, Eunkuk Kim, Jeonghyun Yeo, Subin Kim, Gijeong Ko, Eun-Hee Lee, Sang Woo Li, Wan Yi Choi, Chun Whan Jeong, Seon-Yong Molecules Article Obesity is caused by an excess storage of body fat, resulting from a chronic imbalance between energy intake and expenditure. Gentiana lutea L. (GL) root has been reported to reduce lipid accumulation in the aortic wall of diabetic rats. Here, we performed fractionation and isolation of the bioactive constituent(s) that may be responsible for the antiadipogenic effects of the GL root extract. A single compound, loganic acid, was identified as a candidate component in the 30% ethanol extract of GL. Loganic acid treatment significantly decreased the adipocyte differentiation of 3T3-L1 preadipocytes in a dose-dependent manner. The expression of key adipogenesis-related genes such as adiponectin (Adipoq), peroxisome proliferator-activated receptor gamma (Pparg), lipoprotein lipase (Lpl), perilipin1 (Plin1), fatty acid binding protein 4 (Fabp4), glucose transporter type 4 (Slc2a4), CCAAT/enhancer-binding protein alpha (Cebpa), and tumor necrosis factor-alpha (Tnf) were significantly reduced following treatment with loganic acid. In vivo experiments in an ovariectomy-induced obesity mouse model showed that loganic acid (oral administration with 10 and 50 mg/kg/day) significantly inhibited body weight gain, total fat increase, fatty hepatocyte deposition in the liver, and adipocyte enlargement in the abdominal visceral fat tissues. These results suggest that loganic acid in the GL root extract has antiadipogenic effects in vitro and in vivo. Loganic acid may be beneficial for the prevention and treatment of obesity, particularly in menopausal obese women. MDPI 2018-07-09 /pmc/articles/PMC6100558/ /pubmed/29987205 http://dx.doi.org/10.3390/molecules23071663 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Eunkuk Kim, Jeonghyun Yeo, Subin Kim, Gijeong Ko, Eun-Hee Lee, Sang Woo Li, Wan Yi Choi, Chun Whan Jeong, Seon-Yong Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice |
title | Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice |
title_full | Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice |
title_fullStr | Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice |
title_full_unstemmed | Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice |
title_short | Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice |
title_sort | antiadipogenic effects of loganic acid in 3t3-l1 preadipocytes and ovariectomized mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100558/ https://www.ncbi.nlm.nih.gov/pubmed/29987205 http://dx.doi.org/10.3390/molecules23071663 |
work_keys_str_mv | AT parkeunkuk antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT kimjeonghyun antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT yeosubin antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT kimgijeong antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT koeunhee antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT leesangwoo antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT liwanyi antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT choichunwhan antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice AT jeongseonyong antiadipogeniceffectsofloganicacidin3t3l1preadipocytesandovariectomizedmice |